RxDoctor Payments Data

Alan Andresen, MD

Family Medicine · Tempe, AZNPI 1316908700

Payments from drug & device makers

$21,532in general payments, 2019–2025

Across 1,058 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Novo Nordisk$3K
  • Amgen$3K
  • Lilly USA, LLC$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$963
  • Pfizer$953
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$21,506100%
  • Education$260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)240$3,912
Novo Nordisk130$2,964
Amgen135$2,818
Lilly USA, LLC95$1,494
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC41$963
Pfizer54$953
Abbott34$683
GSK37$661
Eisai Inc.16$565
Johnson & Johnson20$485
AstraZeneca13$468
Novartis19$344
Amarin Pharma, Inc.15$316
Teva Pharmaceuticals USA, Inc.8$314
Boehringer Ingelheim17$311
Merck16$301
Astellas Pharma US Inc10$298
Biosense Webster, Inc.2$241
Phathom Pharmaceuticals, Inc.7$232
Edwards Lifesciences2$223
Takeda Pharmaceuticals U.S.A., Inc.13$186
Biohaven Pharmaceuticals, Inc.6$175
Cleerly, Inc.4$166
Averitas Pharma Inc.3$150
Paratek Pharmaceuticals, Inc.5$143
Idorsia Pharmaceuticals US Inc2$130
Optinose US, Inc.6$125
Biohaven Pharmaceutical Holding Company Ltd.9$121
Corcept Therapeutics6$117
Antares Pharma, Inc.6$94
Impel Pharmaceuticals Inc.4$76
Sanofi Pasteur Inc.4$74
Medtronic(2 entities)3$64
Arbor Pharmaceuticals, Inc.4$61
Inspire Medical Systems, Inc.2$60
Neuronetics, Inc.1$58
Sumitomo Pharma America, Inc.3$58
Itamar Medical Inc2$57
Esperion Therapeutics, Inc.3$56
Almatica Pharma LLC2$55
Genentech USA, Inc.4$52
Hologic Sales And Service, LLC3$49
Axsome Therapeutics, Inc.3$47
Kowa Pharmaceuticals America, Inc.4$47
Scilex Pharmaceuticals Inc.3$46
Gilead2$43
Therapeuticsmd, Inc.3$40
Exact Sciences2$38
Teleflex LLC2$38
Hikma Pharmaceuticals USA3$35
Sanofi1$35
Boston Scientific2$34
Verity Pharmaceuticals Inc.2$34
Globus Medical2$33
E.r. Squibb & Sons, L.L.C.2$31
Actelion Pharmaceuticals US, Inc.1$30
Philips North America LLC1$30
Amneal Pharmaceuticals LLC2$30
Madrigal Pharmaceuticals1$29
Lucid Diagnostics Inc.2$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,532 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$126,603
Medicare patients
450
Services billed
5,435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide12$22,658
EliquisApixaban11$12,975
MounjaroTirzepatide13$12,389
SynthroidLevothyroxine Sodium24$2,650
Levothyroxine Sodium125$1,479
Atorvastatin Calcium137$1,069
Celecoxib19$1,020
Rosuvastatin Calcium54$952
Metoprolol Succinate20$832
Amlodipine Besylate76$730
Escitalopram Oxalate42$565
Tamsulosin Hcl25$528
Zolpidem Tartrate59$493
Olmesartan Medoxomil19$427
Lisinopril48$385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$2,964$22,65812 claims
PfizerEliquis$953$12,97511 claims
Lilly USA, LLCMounjaro$1,494$12,38913 claims
AbbVieSynthroid$3,912$2,65024 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$30$1,479125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Tempe

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →